Skip to main content
. Author manuscript; available in PMC: 2020 Jan 6.
Published in final edited form as: Breast Cancer Res Treat. 2013 Aug 10;141(1):89–99. doi: 10.1007/s10549-013-2662-3

Fig. 4.

Fig. 4

Analysis of LOXL2 expression in two basal-like breast cancer cell lines (MDA-MB-231 and BT549) with LOXL2 silencing. a Western analysis; Cells with LOXL2 silencing by siLOXL2 showed reduced LOXL2, Snail, Snai2, SPARC, p-FAK, and p-SRC at protein level. b RT-PCR analysis; LOXL2 silencing has an effect on reducing of LOXL2, Snail, Snail2, and SPARC at mRNA level